Filling the need for trusted information on national health issues…

Trending on kff Subsidies Marketplaces Enrollment

  • your selections
Clear Search

Filter Results

date

Topics

Tags

Content Type

  • results
  • state & global data
  • slides
Report, Briefing Examine How Seniors Choose Among Their Medicare Plan Options

Report & Briefing Examine How Seniors Choose Among Their Medicare Plan Options Seniors appreciate having a wide range of Medicare private plan choices available to them but often feel unqualified to choose among them, a new Kaiser Family Foundation report concludes. Based on discussions with seniors in four cities around…

Medicare Part D Spending Trends: Understanding Key Drivers and the Role of Competition

This brief commissioned by the Foundation examines factors that contributed to Medicare’s lower-than-expected spending on prescription drugs under the Medicare Part D drug benefit that started in 2006. Since its launch, Medicare has spent about 30 percent less on Part D benefits than the Congressional Budget Office originally projected. Some…

Medicare Part D 2010 Data Spotlights

The Kaiser Family Foundation has issued a collection of analyses related to the Part D Medicare stand-alone drug plan options available to seniors for calendar year 2010. Each of these spotlights focuses on a key aspect of the drug plans that will be available to Medicare beneficiaries in 2010 and…

Prescription Drug Procurement and the Federal Budget

This brief commissioned by the Foundation considers areas where Medicare faces limited opportunity for market-based competition and price negotiation to drive down drug spending. These areas include drug purchasing for low-income people enrolled in Part D plans who face minimal cost-sharing requirements, and purchasing certain unique drugs, such as biologicals,…

Medicare Part D: A First Look at Part D Plan Offerings in 2013

This data spotlight examines the stand-alone Part D drug plan options available to Medicare beneficiaries in 2013 during the open enrollment period, which runs from October 15 to December 7, 2012. The analysis is the first in a series of planned reports examining the private plan choices available to Medicare…

Medicarer Part D 2010 Data Spotlight: Coverage of Top Brand-Name and Specialty Drugs

This Part D Data Spotlight documents the wide variations across the private stand-alone drug plans with respect to coverage of drugs, what enrollees pay for those drugs, and restrictions and limitations placed on their use. These variations have potentially significant implications for beneficiaries’ access to medications and out-of-pocket costs. The…

Medicare Prescription Drug Plans In 2010 and Key Changes Over Five Years

This brief summarizes key findings from the full collection of 2010 Part D Data Spotlights examining key trends in the private stand-alone drug plans available to Medicare beneficiaries. The spotlight is one in a series analyzing key aspects of the Medicare Part D drug plans that will be available to…

Medicare Part D Data Spotlight: A First Look at Part D Plan Offerings in 2012

This data spotlight examines the stand-alone Part D drug plan options available to Medicare beneficiaries in 2012. Medicare beneficiaries will, on average, be able to choose from 31 stand-alone Medicare Part D prescription drug plans to choose from, a new Kaiser analysis finds. Average premiums would increase by 4 percent…

Analysis of Medicare Prescription Drug Plans In 2012 And Key Trends Since 2006

This report presents findings from an analysis of the Medicare Part D marketplace in 2012 and changes in drug coverage and costs since 2006. It presents key findings related to Medicare drug plan plan availability, premiums, cost-sharing, the coverage gap and availability for low-income beneficiaries, the coverage gap, benefit design…